Stay updated on Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page.

Latest updates to the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNew version entries show updates to the study and recruitment statuses, including a suspended state. The record now includes PI actions and Contacts/Locations sections, while older items such as 'Check who can join' and 'Find Contact Information' appear to have been removed in newer revisions.SummaryDifference0.8%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedAn updated revision tag appears in the history: v3.6.3 replaces v3.6.0, signaling a newer version of the study record on this page.SummaryDifference0.1%

- Check46 days agoChange DetectedNew quick-access actions were added to the history page: 'Check who can join' and 'Find Contact Information', improving navigation to eligibility and contact details. The page now displays Revision: v3.6.0 and removes the previous Revision: v3.5.5 entry.SummaryDifference0.3%

- Check53 days agoChange DetectedA new revision entry, v3.5.5, has been added to the history and the prior v3.5.4 entry has been removed. This reflects an updated release noted in the page's revision history.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision (v3.5.4) was added to the page, replacing the previous revision (v3.5.3) in the history. This updates the revision metadata for the study record history.SummaryDifference0.1%

- Check96 days agoChange DetectedThe page’s footer revision label was updated from **v3.5.2** to **v3.5.3**, indicating a minor ClinicalTrials.gov site/version update rather than a change to the recorded trial information.SummaryDifference0.1%

Stay in the know with updates to Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib-Decitabine-Venetoclax Combo in AML Clinical Trial page.